Global Healthcare CMO Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Healthcare CMO Market Research Report 2024
Industry and government regulations have forced enterprises to outsource manufacturing operations to the third party to remain competitive and enhance business process efficiency. Increasing investment in the healthcare sector has also provided the necessary impetus to the market.
According to MRAResearch’s new survey, global Healthcare CMO market is projected to reach US$ 160510 million in 2033, increasing from US$ 80480 million in 2022, with the CAGR of 9.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Healthcare CMO market research.
Key companies engaged in the Healthcare CMO industry include Accellent, Boehringer Ingelheim, Catalent, DSM, Fareva, Greatbatch, Lonza, Patheon and Piramal, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Healthcare CMO were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Healthcare CMO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Healthcare CMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Accellent
Boehringer Ingelheim
Catalent
DSM
Fareva
Greatbatch
Lonza
Patheon
Piramal
Tecomet
Segment by Type
Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging)
Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly)
Final Goods Assembly
Pharmaceutical
Biotechnology Industry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Healthcare CMO report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Healthcare CMO market is projected to reach US$ 160510 million in 2033, increasing from US$ 80480 million in 2022, with the CAGR of 9.9% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Healthcare CMO market research.
Key companies engaged in the Healthcare CMO industry include Accellent, Boehringer Ingelheim, Catalent, DSM, Fareva, Greatbatch, Lonza, Patheon and Piramal, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Healthcare CMO were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Healthcare CMO market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Healthcare CMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Accellent
Boehringer Ingelheim
Catalent
DSM
Fareva
Greatbatch
Lonza
Patheon
Piramal
Tecomet
Segment by Type
Pharmaceutical Contract Manufacturing Services (Active Pharmaceutical Ingredients (API) Manufacturing, Final Dosage Form (FDF) Manufacturing, and Packaging)
Medical Device Contract Manufacturing Services (Outsourcing Design, Device Manufacturing (Material Process Services, Electronic Manufacturing Services, and Finished Products), and Final Goods Assembly)
Final Goods Assembly
Segment by Application
Pharmaceutical
Biotechnology Industry
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Healthcare CMO report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source